{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:42:28Z","timestamp":1782736948842,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["Pest-OE\/SAU\/UI4013\/2014"],"award-info":[{"award-number":["Pest-OE\/SAU\/UI4013\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["REDE\/1501\/REM\/2005"],"award-info":[{"award-number":["REDE\/1501\/REM\/2005"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["ROTEIRO\/0028\/2013"],"award-info":[{"award-number":["ROTEIRO\/0028\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["LISBOA-01-0145-FEDER-022125"],"award-info":[{"award-number":["LISBOA-01-0145-FEDER-022125"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["PTDC\/SAU-FAR\/118459\/2010"],"award-info":[{"award-number":["PTDC\/SAU-FAR\/118459\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT)","doi-asserted-by":"publisher","award":["SFRH\/BPD\/100645\/2014"],"award-info":[{"award-number":["SFRH\/BPD\/100645\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejmech.2018.02.048","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T07:33:28Z","timestamp":1519025608000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability"],"prefix":"10.1016","volume":"149","author":[{"given":"Rita","family":"Capela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Sanches-Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas S.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Frade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-9852","authenticated-orcid":false,"given":"Rui","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Prud\u00eancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-147X","authenticated-orcid":false,"given":"Francisca","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.02.048_bib1","series-title":"World Malaria Report","author":"WHO","year":"2015"},{"key":"10.1016\/j.ejmech.2018.02.048_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pt.2011.09.004","article-title":"A\u00a0toolbox to study liver stage malaria","volume":"27","author":"Prudencio","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2018.02.048_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/jm201095h","article-title":"Targeting the liver stage of malaria parasites: a yet unmet goal","volume":"55","author":"Rodrigues","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2018.02.048_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004871","article-title":"Targeting human transmission biology for malaria elimination","volume":"11","author":"Nilsson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2018.02.048_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.02.048_bib7","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malaria J."},{"key":"10.1016\/j.ejmech.2018.02.048_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000406","article-title":"m.C.G. drugs, a research agenda for malaria eradication: drugs","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2018.02.048_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib10","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/0960-894X(95)00400-N","article-title":"The effect of fluorine substitution on the haemotoxicity of primaquine","volume":"5","author":"Oneill","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.02.048_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/138955708783744092","article-title":"Malaria combination therapies: advantages and shortcomings","volume":"8","author":"Martinelli","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.02.048_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.02.048_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2018.02.048_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A\u00a0molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.02.048_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-resistant Plasmodium falciparum malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2018.02.048_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Accounts Chem. Res."},{"key":"10.1016\/j.ejmech.2018.02.048_bib18","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmcl.2009.04.100","article-title":"Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition","volume":"19","author":"Capela","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.02.048_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2015.06.045","article-title":"Primaquine-pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity","volume":"101","author":"Kaur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib20","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/jm5004528","article-title":"Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials","volume":"57","author":"Oliveira","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib21","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.bmc.2015.04.017","article-title":"From hybrid compounds to targeted drug delivery in antimalarial therapy","volume":"23","author":"Oliveira","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib22","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cmdc.201300202","article-title":"An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites","volume":"8","author":"Oliveira","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.02.048_bib23","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bmc.2016.03.005","article-title":"Novel squaramides with in\u00a0vitro liver stage antiplasmodial activity","volume":"24","author":"Ribeiro","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000406","article-title":"A\u00a0research agenda to underpin malaria eradication","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2018.02.048_bib25","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy","volume":"55","author":"Capela","year":"2011","journal-title":"Antimicrob. Agents Ch."},{"key":"10.1016\/j.ejmech.2018.02.048_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/ml4002985","article-title":"Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activities","volume":"5","author":"Miranda","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.02.048_bib27","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/S0021-9258(19)50504-X","article-title":"Hydroxylated metabolites of the antimalarial drug primaquine - oxidation and redox cycling","volume":"267","author":"Vasquezvivar","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/jm100911f","article-title":"Antimalarial activity of novel 5-Aryl-8-aminoquinoline derivatives","volume":"54","author":"Shiraki","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/jm00218a026","article-title":"Modifications of primaquine as antimalarials .1. 5-phenoxy derivatives of primaquine","volume":"20","author":"Chen","year":"1977","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.02.048_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1023\/A:1018922425551","article-title":"Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates","volume":"16","author":"Portela","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2018.02.048_bib31","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/ja01623a038","article-title":"Synthesis of primaquine and certain of its analogs","volume":"77","author":"Elderfield","year":"1955","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.02.048_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/cr00002a004","article-title":"A\u00a0survey of hammett substituent constants and resonance and field parameters","volume":"91","author":"Hansch","year":"1991","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.02.048_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-11-259","article-title":"CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine","volume":"11","author":"Pybus","year":"2012","journal-title":"Malaria J."},{"key":"10.1016\/j.ejmech.2018.02.048_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","article-title":"A\u00a0microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax","volume":"14","author":"March","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2018.02.048_bib35","article-title":"Inhibition of plasmodium hepatic infection by antiretroviral compounds","volume":"7","author":"Machado","year":"2017","journal-title":"Front. Cell. Infect. Mi."},{"key":"10.1016\/j.ejmech.2018.02.048_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cmdc.201500011","article-title":"Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids","volume":"10","author":"Rodrigues","year":"2015","journal-title":"Chem. Med. Chem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T14:09:01Z","timestamp":1660486141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418301843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"alternative-id":["S0223523418301843"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.048","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}